Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: Implications for the detection of growth hormone abuse in sport

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 6, 2010, Pages 2969-2976

  Guha, Nishan ^a   Erotokritou Mulligan, Ioulietta ^a   Burford, Caroline ^a   Strobridge, Gail ^a   Brigg, Joanna ^a   Drake, Tamsin ^a   Bassett, E Eryl ^b   Cowan, David ^c   Bartlett, Christiaan ^c   Sönksen, Peter H ^a   Holt, Richard I G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOMATOMEDIN C; COLLAGEN TYPE 3; EPITOPE; HUMAN GROWTH HORMONE; PROCOLLAGEN;

ADOLESCENCE; ADOLESCENT; ADULT; ARTICLE; ATHLETE; CHILD; DOPING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; AGING; BLOOD; BODY HEIGHT; BODY MASS; BODY WEIGHT; CROSS-SECTIONAL STUDY; LABORATORY DIAGNOSIS; METABOLISM; METHODOLOGY; PHYSIOLOGY; REPRODUCIBILITY; SEXUAL DEVELOPMENT; SPORT; SUBSTANCE ABUSE;

ADOLESCENT; AGING; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; COLLAGEN TYPE III; CROSS-SECTIONAL STUDIES; DOPING IN SPORTS; EPITOPES; FALSE POSITIVE REACTIONS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; PROCOLLAGEN; REPRODUCIBILITY OF RESULTS; SEX CHARACTERISTICS; SPORTS; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 77954508591     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0008     Document Type: Article

References (28)

1. Holt RI, Sönksen PH 2008 Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol 154:542-556
2. Powrie JK, Bassett EE, Rosen T, Jørgensen JO, Napoli R, Sacca L, Christiansen JS, Bengtsson BA, Sönksen PH 2007 Detection of growth hormone abuse in sport. Growth Horm IGF Res 17:220-226
3. Martha Jr PM, Gorman KM, Blizzard RM, Rogol AD, Veldhuis JD 1992 Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass. J Clin Endocrinol Metab 74:336-344
4. Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, Sheffield-Moore M, Mauras N, Bowers CY 2005 Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev 26:114-146
5. Mauras N, Bishop K, Welch S 2007 Growth hormone action in puberty: effects by gender. Growth Horm IGF Res 17:463-471
6. Rickert VI, Pawlak-Morello C, Sheppard V, Jay MS 1992 Human growth hormone: a new substance of abuse among adolescents? Clin Pediatr (Phila) 31:723-726
7. Cowan DA, Bartlett C 2009 Laboratory issues in the implementation of the marker method. Growth Horm IGF Res 19:357-360
8. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA 1995 Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 73:17-24
9. Longobardi S, Keay N, Ehrnborg C, Cittadini A, Rosén T, Dall R, Boroujerdi MA, Bassett EE, Healy ML, Pentecost C, Wallace JD, Powrie J, Jørgensen JO, Saccà L 2000 Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab 85:1505-1512
10. Healy ML, Dall R, Gibney J, Bassett E, Ehrnborg C, Pentecost C, Rosen T, Cittadini A, Baxter RC, Sönksen PH 2005 Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. J Clin Endocrinol Metab 90:641-649
11. Erotokritou-Mulligan I, Bassett EE, Bartlett C, Cowan D, McHugh C, Seah R, Curtis B, Wells V, Harrison K, Sönksen PH, Holt RI 2008 The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes. J Clin Endocrinol Metab 93:2760-2763
12. Erotokritou-Mulligan I, Bassett EE, Cowan DA, Bartlett C, McHugh C, Sönksen PH, Holt RI 2009 The influence of ethnicity on insulin like growth factor-I and procollagen III peptide in elite athletes and its effect on the ability to detect GH abuse. Clin Endocrinol (Oxf) 70:161-168
13. Wheeler MD 1991 Physical changes of puberty. Endocrinol Metab Clin North Am 20:1-14
14. Stanhope R, Albanese A, Hindmarsh P, Brook CG 1992 The effects of growth hormone therapy on spontaneous sexual development. Horm Res 38(Suppl 1):9-13
15. Laron Z 1999 Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome). J Pediatr Endocrinol Metab 12(Suppl 1):231-249
16. Arsenijevic Y, Wehrenberg WB, Conz A, Eshkol A, Sizonenko PC, Aubert ML 1989 Growth hormone (GH) deprivation induced by passive immunization against rat GH-releasing factor delays sexual maturation in the male rat. Endocrinology 124:3050-3059
17. Löfqvist C, Andersson E, Gelander L, Rosberg S, Blum WF, Albertsson Wikland K 2001 Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab 86:5870-5876
18. Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, Rasmussen S, Müller J, Skakkebaek NE 1997 Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 82:2497-2502
19. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jørgensen K, Müller J, Hall K, Skakkebaek NE 1994 Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78:744-752
20. Crofton PM, Wade JC, Taylor MR, Holland CV 1997 Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren. Clin Chem 43:1577-1581
21. Trivedi P, Hindmarsh P, Risteli J, Risteli L, Mowat AP, Brook CG 1989 Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen. J Pediatr 114:225-230
22. Sorva R, Anttila R, Siimes MA, Sorva A, Tähtelä R, Turpeinen M 1997 Serum markers of collagen metabolism and serum osteocalcin in relation to pubertal development in 57 boys at 14 years of age. Pediatr Res 42:528-532
23. Erotokritou-Mulligan I, Eryl Bassett E, Cowan D, Bartlett C, Milward P, Sartorio A, Sonksen PH, Holt RI 2010 The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score. Clin Endocrinol (Oxf) 72:520-526
24. Granada ML, Ulied A, Casanueva FF, Pico A, Lucas T, Torres E, Sanmartí A 2008 Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population. Clin Endocrinol (Oxf) 68:942-950
25. Quarmby V, Quan C, Ling V, Compton P, Canova-Davis E 1998 How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy. J Clin Endocrinol Metab 83:1211-1216
26. Saugy M, Cardis C, Robinson N, Schweizer C 2000 Test methods: anabolics. Baillieres Best Pract Res Clin Endocrinol Metab 14:111-133
27. Bredehöft M, Schänzer W, Thevis M 2008 Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun Mass Spectrom 22:477-485
28. Abellan R, Ventura R, Pichini S, Pascual JA, Pacifici R, Di Carlo S, Bacosi A, Segura J, Zuccaro P 2005 Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport. Clin Chem Lab Med 43:75-85